DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trelstar (Triptorelin Pamoate) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

TRELSTAR SUMMARY

TRELSTAR™ DEPOT contains a pamoate salt of triptorelin, and triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH or GnRH) with greater potency than the naturally occurring LHRH.

TRELSTAR™ DEPOT is indicated in the palliative treatment of advanced prostate cancer. It offers an alternative treatment for prostate cancer when orchiectomy or estrogen administration are either not indicated or unacceptable to the patient.


See all Trelstar indications & dosage >>

TRELSTAR NEWS HIGHLIGHTS

Media Articles Related to Trelstar (Triptorelin)

AACR: Daily Aspirin Could Obscure Prostate Cancer in Some Men
Source: MedPage Today Cardiovascular [2008.11.17]

Gene Screen Might Predict Prostate Cancer (HealthDay)
Source: Y! Health Cancer & Chemotherapy News [2008.11.17]

Aspirin may mask prostate cancer, study hints (Reuters)
Source: Y! Health Prostate Cancer News [2008.11.17]

Treatment Of Patients After Failed High Intensity Focused Ultrasound And Radiotherapy For Localized Prostate Cancer
Source: Breast Cancer News From Medical News Today [2008.11.16]

New Findings Offer Fresh Hope To Men With Prostate Cancer That Has Returned After Attempted Cure
Source: Cancer / Oncology News From Medical News Today [2008.11.16]

more >>

Published Studies Related to Trelstar (Triptorelin)

A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. [2008.02]

Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer. [2008.01.10]

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916). [2007.09]

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916). [2007.07.17]

A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. [2006.12.16]

more >>

Clinical Trials Related to Trelstar (Triptorelin)

Study to Assess the Non-Inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) [Recruiting]

Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women [Not yet recruiting]

Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty [Recruiting]

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin [Completed]

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Recruiting]

more >>

Page last updated: 2008-11-17

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008